Peak Pharmaceuticals, Inc. filed its 10-K on Dec 19, 2022 for the period ending Sep 30, 2021. In this report its auditor, Friedman LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.1 USD | -44.00% |
|
0.00% | +21.39% |
1st Jan change | Capi. | |
---|---|---|
+21.39% | 43.94M | |
+19.61% | 3,343B | |
+17.60% | 92.78B | |
+16.90% | 87.29B | |
+38.85% | 53.09B | |
-21.37% | 48.57B | |
+35.78% | 47.79B | |
+86.22% | 43.32B | |
-31.70% | 42.29B | |
-1.70% | 27.69B |
- Stock Market
- Equities
- RMHI Stock
- News Retrieve Medical Holdings Inc
- Peak Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt